Advanced search
Publication Cover
Journal of Medical Economics Volume 26, 2023 - Issue 1
Submit an article Journal homepage
1,441
Views
1
CrossRef citations to date
0
Altmetric
Health Financing

Assessing the impact of single or short-term administration on a therapy’s cost-effectiveness: a hypothetical disease-agnostic model

Alexa C. Klimchaka Sarepta Therapeutics, Inc, Cambridge, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8196-7093
ORCID Icon,
Lauren E. Seditaa Sarepta Therapeutics, Inc, Cambridge, MA, USAORCID Iconhttps://orcid.org/0000-0003-0899-1585
ORCID Icon,
Katherine L. Goocha Sarepta Therapeutics, Inc, Cambridge, MA, USA
&
Daniel C. Maloneb College of Pharmacy, University of Utah, Salt Lake City, UT, USAORCID Iconhttps://orcid.org/0000-0002-5006-9394
ORCID Icon
Pages 594-602 | Received 15 Mar 2023, Accepted 04 Apr 2023, Published online: 23 Apr 2023

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alexa C. Klimchak, Lauren E. Sedita, Louise R. Rodino-Klapac, Jerry R. Mendell, Craig M. McDonald, Katherine L. Gooch & Daniel C. Malone. (2023) Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States. Journal of Market Access & Health Policy 11:1.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.